KINOMEscan® Kinase Screening and Profiling Services
With over 15 years of experience in kinase drug discovery, Eurofins DiscoverX offers the largest collection of nearly 500 biochemical and cell-based kinase assays. KINOMEscan, our novel kinase inhibitor binding platform, includes an industry leading set of kinase assays that allow rapid determination of kinome-wide compound potency and selectivity. Investigators can also profile compounds across small custom selectivity panels, conduct dose response curves to measure inhibitor potency, or screen 100 to 1,000,000 compounds against a single target. With the fastest turnaround time and broad dynamic range, KINOMEscan services enable expedited SAR analysis.